FDA Clearance Tracker · P160055-S027
Light Adjustable Lens, Light Delivery Device
Last checked: Nov 20, 2026Latest source record: Feb 16, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Feb 16, 2023
Approved
Time to decision
70 days
Received Dec 8, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P160055-S027
- Device name
- Light Adjustable Lens, Light Delivery Device
- Applicant
- Rxsight, Inc.
- Applicant location
- Aliso Viejo, CA
- Received
- Dec 8, 2022
- Decided
- Feb 16, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P160055
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for Rxsight, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261174 · Decided Jun 10, 2026 · 62 days after receipt
Device type: Folders And Injectors, Intraocular Lens (Iol) (MSS) · Ophthalmology
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.